Sareum Holdings (GB:SAR) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sareum Holdings PLC, a biotech firm developing treatments for autoimmune disease and cancer, has announced the final issue of new Ordinary Shares to RiverFort Global Opportunities, settling the outstanding balance of the Riverfort Facility. The company will not make further withdrawals or issue more shares under this facility. Following the issue, the total shares in circulation and total voting rights will amount to 106,838,797.
For further insights into GB:SAR stock, check out TipRanks’ Stock Analysis page.